Nancy Becker
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Antimicrobial Resistance in Staphylococcus 2
- COVID-19 Clinical Research Studies 1
- Co-authors
- Barbara L. O’Brien (4 shared papers)G. Arcieri (4 shared papers)Allen Heyd (4 shared papers)Soo‐Sang Kang (1 shared paper)PAUL W. K. WONG (1 shared paper)Eric C. Griffith (2 shared papers)Catherine Chambliss (2 shared papers)Elizabeth C. Griffith (2 shared papers)
- Journals
- The Journal of Infectious Diseases (1 paper)The Journal of Clinical Pharmacology (1 paper)The American Journal of Medicine (1 paper)American Journal of Critical Care (1 paper)Pediatric Research (1 paper)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Nancy Becker
17 papers receiving 440 citations
Peers
Comparison fields: 5 of 100
- Molecular Medicine 60
- Pharmacology 180
- Clinical Biochemistry 65
- Music 20
- Rheumatology 78
Countries citing papers authored by Nancy Becker
This map shows the geographic impact of Nancy Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Becker more than expected).
Fields of papers citing papers by Nancy Becker
This network shows the impact of papers produced by Nancy Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Becker. The network helps show where Nancy Becker may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Becker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ciprofloxacin: an update on clinical experience. | 1987 | 121 |
| 2 | 1979 | 89 | |
| 3 | 1986 | 61 | |
| 4 | 1989 | 51 | |
| 5 | 1994 | 42 | |
| 6 | 2013 | 29 | |
| 7 | 2022 | 24 | |
| 8 | 1995 | 23 | |
| 9 | 1988 | 19 | |
| 10 | 2023 | 14 | |
| 11 | 2024 | 9 | |
| 12 | 2001 | 4 | |
| 13 | 2015 | 3 | |
| 14 | 2023 | 2 | |
| 15 | Performance Standards for Restaurants | 2013 | 2 |
| 16 | Facing our Future: Infrastructure Investments Necessary for Economic Success | 2013 | 1 |
| 17 | 2010 | 1 |
About Nancy Becker
Nancy Becker is a scholar working on Pharmacology, Infectious Diseases, Clinical Biochemistry, Orthopedics and Sports Medicine and Applied Microbiology and Biotechnology, having authored 17 papers that have together received 495 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Sports Performance and Training (2 papers), Ocular Infections and Treatments (1 paper), Music Therapy and Health (1 paper), COVID-19 Clinical Research Studies (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Peripheral Artery Disease Management (1 paper). The work is most often cited by research in Molecular Medicine (60 citations), Pharmacology (180 citations), Clinical Biochemistry (65 citations), Music (20 citations) and Rheumatology (78 citations). Nancy Becker has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Barbara L. O’Brien, G. Arcieri, Allen Heyd, Soo‐Sang Kang, PAUL W. K. WONG, Eric C. Griffith, Catherine Chambliss, Elizabeth C. Griffith, Colleen Doyle and Barbara Esposito. Their work appears in journals such as The Journal of Infectious Diseases, The Journal of Clinical Pharmacology, The American Journal of Medicine, American Journal of Critical Care and Pediatric Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.